3 items
Results from an earlier clinical trial confirmed the benefit of using Avastin over laser therapy for treating the most severe cases of ROP, which occur in a region of the retina known as posterior zone 1, as shown.

Very low-dose Avastin effective for preventing blindness in preterm infants

April 23, 2020

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.
A fundus image shows an eye with aggressive posterior retinopathy of prematurity (AP-ROP). The i-ROP DL deep learning system quantified the dilation and tortuosity of the retinal vessels, which both occur to a high degree in AP-ROP.

AI may help spot newborns at risk for most severe form of blinding disease

March 4, 2020

An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP.
Small baby sleeping in hospital

Tech that detects cause of preemie blindness gets federal nod

January 30, 2020

An artificial intelligence algorithm that can detect a potentially devastating cause of childhood blindness better than most human experts has been granted breakthrough status by the FDA.